1. Home
  2. ATR vs ICLR Comparison

ATR vs ICLR Comparison

Compare ATR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AptarGroup Inc.

ATR

AptarGroup Inc.

HOLD

Current Price

$121.37

Market Cap

8.1B

Sector

Industrials

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$111.78

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATR
ICLR
Founded
1992
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.2B
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
ATR
ICLR
Price
$121.37
$111.78
Analyst Decision
Buy
Buy
Analyst Count
4
13
Target Price
$170.25
$178.62
AVG Volume (30 Days)
401.2K
1.3M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
1.56%
N/A
EPS Growth
6.51
N/A
EPS
1.12
N/A
Revenue
$3,777,181,000.00
N/A
Revenue This Year
$5.18
N/A
Revenue Next Year
$4.98
N/A
P/E Ratio
$108.06
$12.91
Revenue Growth
5.42
N/A
52 Week Low
$103.23
$66.57
52 Week High
$164.28
$211.00

Technical Indicators

Market Signals
Indicator
ATR
ICLR
Relative Strength Index (RSI) 39.81 50.98
Support Level $118.91 $102.53
Resistance Level $125.35 $116.85
Average True Range (ATR) 3.81 5.50
MACD -0.64 0.28
Stochastic Oscillator 27.32 57.67

Price Performance

Historical Comparison
ATR
ICLR

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: